English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

China's Hebang Group acquires 51% stake of Stockton Group for $90 millionqrcode

Jun. 30, 2015

Favorites Print
Forward
Jun. 30, 2015

STK
Israel  Israel
Follow

On June 29, 2015, Chinese company Hebang Group announced that it has acquired 51% stake of the Israeli Stockton Group for $90 million.

The Hebang Group is a public Chinese company, traded on the Shanghai Stock Exchange, and is active in a variety of industrial activities, including the agrochemical industry. This is the Hebang Group’s first investment outside of China.

Stockton, a global crop protection company and a leader in the development of botanical based biopesticides founded 20 years ago by Peter Tirosh and managed by Ziv Tirosh, developed its first environmentally-friendly biofungicide, Timorex Gold. The product is successfully sold in nearly 20 countries to treat a large number of crops, such as rice, coffee, grapes, tomatoes, bananas and a wide variety of other fruits and vegetables.

Hebang’s goal with this investment in Stockton is to “support Stockton’s growth as a global leader in environmentally-friendly biofungicides.”

Stockton recently received a license to sell Timorex Gold in the United States. The investment from Hebang will allow Stockton to accelerate its penetration into this and additional markets, as well as to advance the development of other environmentally-friendly products through ongoing cooperation with research and academic institutes in Israel and around the world.

Ziv Tirosh, Stockton’s CEO, noted that the company is currently in the process of receiving regulatory approval in China, and the partnership with Hebang will assist with penetration into the Asia.

According to the agreement, Stockton will continue to operate as an Israeli company with no change to its management, while the controlling shareholder of Hebang, Mr. He Zhenggang, will serve as the company’s chairman following the investment.

The transaction is expected to close within 90 days, subject to regulatory approvals in China.



0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox